🔴 Eupraxia Pharmaceuticals is trading 11% down today with no clear company-specific catalyst reported

Eupraxia Pharmaceuticals is trading 10.99% down at $8.10, with no clear company-specific news reported on October 1 explaining the decline.

• Shares rose 9.57% to $9.10 on September 30 after the company reported 52-week clinical data; that update does not establish a cause for the current drop.
• XLV was reported down about 1.3% during the session; broader indices showed only modest declines, and evidence does not establish a specific catalyst for the larger move.